MedTrace Logo

Perioperative Lignocaine and Sleep Disturbance

NCT03317912 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-10-23

No results posted yet for this study

Summary

The aim of this clinical trial is to study the effect of an intravenous infusion of lidocaïne in a multimodal analgesic protocol on the architecture sleep during the first postoperative night.

Conditions

  • Sleep Disturbance

Interventions

DRUG

Lidocaïne 2%

Continuous infusion during per and postoperative periods

DRUG

Placebo (for Lidocaïne)

Continuous infusion during per and postoperative periods

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Isabelle Maquoi · CHU Liege - Department of Anesthesia and Intensive Care Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03317912 on ClinicalTrials.gov